Chloroquine Phosphate Tablets Manufacturer from Thane

Chloroquine Phosphate Tablets

Rs 150 / Stripe

Dosage Form: Tablet, Capsule
Dose/Strength: 150 mg
Composition: Chloroquine phosphate BP 250 mg
Molecular formula: C18H26CIN3.2H3PO4
Molecular weight: 515.87

For suppressive treatment and for acute attacks of malaria, we are offering best quality of Yashiquin Tablet.

This is known for its effective results in short period of time.

It contain chloroquine phosphate is a 4-aminoquinoline compound and chemically it is 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino] quinoline phosphate (1:2).

These are available in safe packaging and kept in cool area to maintain their longer shelf life.

These are safe to consume but in limited doses that a person can take after consulting the doctor.

Composition:	Each film coated tablet contains: chloroquine phosphate BP 250 mg eq. to chloroquine base 150 mg, excipients Q S, Approved colour used.
Molecular formula:	C18H26CIN3.2H3PO4
Molecular weight:	515.87
Indications:	Chloroquine phosphate tablets are indicated for suppressive treatment and for acute attacks of malaria due to P. vivax, P. malariae, P. ovale and susceptible strains of P. falciparum. The drug is also indicated for the treatment of extraintestinal amebiasis.
Dosage and administration:	As directed by the physician. The dosage of chloroquine phosphate is often expressed in terms of equivalent chloroquine base. Each 250 mg tablet of chloroquine phosphate is equivalent to 150 mg base.
For malaria suppression:	Adult Dose: 500 mg (= 300 mg base) on exactly the same day of each week. Pediatric Dose: The weekly suppressive dosage is 5 mg calculated as base, per kg of body weight, but should not exceed the adult dose regardless of weight. If circumstances permit, suppressive therapy should begin two weeks prior to exposure. The suppressive therapy should be continued for eight weeks after leaving the endemic area.
For treatment of acute attack:	Adults: An initial dose of 1 g (= 600 mg base) followed by an additional 500 mg (= 300 mg base) after six to eight hours and a single dose of 500 mg (= 300 mg base) on each of two consecutive days. This represents a total dose of 2.5 g chloroquine phosphate of 1.5 g base in three days. The dosage for adults of low body weight and for infants and children should be determined as follows: First dose: 10 mg base/kg (but not exceeding a single dose of 600 mg base). Second dose: (6 hours after first dose) 5 mg base/kg (but not exceeding a single dose of 300 mg base). Third dose: (24 hours after first dose) 5 mg base/kg. Fourth dose: (36 hours after first dose) 5 mg base/kg. For radical cure of vivax and malariae malaria concomitant therapy with an 8-aminoquinoline compound is necessary.